Browsing: RSV

By Yadarisa Shabong and Maggie Fick (Reuters) -GSK on Wednesday said its vaccine sales would fall this year, after a…

By Michael Erman (Reuters) – U.S. sales of RSV vaccines from GSK and Pfizer (NYSE:) are down significantly after regulators…

By Patrick Wingrove (Reuters) – One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher…

The Food and Drug Administration on Friday expanded the approval of GSK’s respiratory syncytial virus vaccine to adults ages 50…

The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above,…

By Michael Erman (Reuters) – Pfizer (NYSE:) said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated…